Literature DB >> 24141176

Experiences in recruiting volunteers through community based initiatives in phase-1 vaccine trials in India.

Seema Sahay1, Makesh Kumar2, Aylur K Srikrishnan3, Vadakkuppatu Ramanathan2, Sanjay Mehendale4.   

Abstract

Success of HIV vaccine trials is dependent on infrastructural preparedness of the site, technical expertise of the trial team and strong Socio-political support of the local community. The processes followed and experiences gained while implementing various community based initiatives for recruitment of healthy volunteers during the three HIV vaccine trials in India are described. Major initiatives in community engagement implemented for the first time in India included establishment and involvement of Community Advisory Board and capacity building and engagement of lay community based volunteers called "peers" using "lay health promotion" model. Community education program designed for trial participants' education, identification and enrollment was a three-tiered approach, moving from large community awareness meetings (first step) to facility-based small group meeting to provide trial specific information (second step); ending with one-to-one vaccine center based meeting with the volunteers to clear doubts, myths, and misconceptions about HIV/AIDS, the experimental vaccine and HIV vaccine trials as well as to explain trial specific procedures (third step). It is important to focus on gender issues, locally relevant socio-cultural factors, informed consent, and post-trial care related matters during the conduct of sensitive clinical trials in socio-culturally diverse and resource limited setting like India.

Entities:  

Keywords:  Community Advisory Board; Phase 1 HIV vaccine trial; autonomy; community engagement; gender issues; peer; recruitment; trial participation; volunteers

Mesh:

Substances:

Year:  2013        PMID: 24141176      PMCID: PMC4185896          DOI: 10.4161/hv.26799

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  34 in total

1.  Why blacks do not take part in HIV vaccine trials.

Authors:  Demetrius L Moutsiakis; P Nancy Chin
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

2.  'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials.

Authors:  Jennifer Koen; Zaynab Essack; Catherine Slack; Graham Lindegger; Peter A Newman
Journal:  Dev World Bioeth       Date:  2012-09-24       Impact factor: 2.294

3.  Engaging community to support HIV prevention research.

Authors:  Seema Sahay; Sanjay Mehendale
Journal:  East J Med       Date:  2011

4.  Facing the challenge: household responses to HIV/AIDS in Mumbai, India.

Authors:  S Bharat; P Aggleton
Journal:  AIDS Care       Date:  1999-02

5.  Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.

Authors:  Clayton D Harro; Franklyn N Judson; Geoffrey J Gorse; Kenneth H Mayer; Jay R Kostman; Stephen J Brown; Beryl Koblin; Michael Marmor; Bradford N Bartholow; Vladimir Popovic
Journal:  J Acquir Immune Defic Syndr       Date:  2004-11-01       Impact factor: 3.731

6.  Increasing participation of women in early phase clinical trials approved by the FDA.

Authors:  Ellen Pinnow; Pellavi Sharma; Ameeta Parekh; Natalie Gevorkian; Kathleen Uhl
Journal:  Womens Health Issues       Date:  2009 Mar-Apr

7.  Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.

Authors:  Paula M Frew; Carlos del Rio; Lu Lu; Sarah Clifton; Mark J Mulligan
Journal:  J Acquir Immune Defic Syndr       Date:  2009-03-01       Impact factor: 3.731

8.  Opt-out as an acceptable method of obtaining consent in medical research: a short report.

Authors:  Akke Vellinga; Martin Cormican; Belinda Hanahoe; Kathleen Bennett; Andrew W Murphy
Journal:  BMC Med Res Methodol       Date:  2011-04-06       Impact factor: 4.615

9.  "If It's Not Working, Why Would They Be Testing It?": mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India.

Authors:  Venkatesan Chakrapani; Peter A Newman; Neeti Singhal; Ruban Nelson; Murali Shunmugam
Journal:  BMC Public Health       Date:  2013-08-07       Impact factor: 3.295

10.  Motives for participating in a clinical research trial: a pilot study in Brazil.

Authors:  Solange A Nappo; Giovanna B Iafrate; Zila M Sanchez
Journal:  BMC Public Health       Date:  2013-01-10       Impact factor: 3.295

View more
  6 in total

1.  What empirical research has been undertaken on the ethics of clinical research in India? A systematic scoping review and narrative synthesis.

Authors:  Sangeetha Paramasivan; Philippa Davies; Alison Richards; Julia Wade; Leila Rooshenas; Nicola Mills; Alba Realpe; Jeffrey Pradeep Raj; Supriya Subramani; Jonathan Ives; Richard Huxtable; Jane M Blazeby; Jenny L Donovan
Journal:  BMJ Glob Health       Date:  2021-05

2.  Altruism, Scepticism, and collective decision-making in foreign-born U.S. residents in a tuberculosis vaccine trial.

Authors:  Sienna R Craig; Timothy Lahey; Apoorva Dixit; C Fordham von Reyn
Journal:  BMC Public Health       Date:  2018-04-23       Impact factor: 3.295

3.  Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.

Authors:  Rachel Colin-Jones; Mila Shakya; Merryn Voysey; Katherine Theiss-Nyland; Nicola Smith; Dikshya Pant; Xinxue Liu; Susan Tonks; Olga Mazur; Yama G Farooq; Sarah Kelly; Anup Adhikari; Sabina Dongol; Abhilasha Karkey; Shrijana Shrestha; Buddha Basnyat; Andrew J Pollard
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079

4.  Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt.

Authors:  Ashata Dahal; Mila Shakya; Dikshya Pant; Anup Adhikari; Rachel Colin-Jones; Katherine Theiss-Nyland; Andrew J Pollard; Buddha Basnyat; Shrijana Shrestha
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

5.  Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.

Authors:  Borna A Nyaoke; Gaudensia N Mutua; Rose Sajabi; Delvin Nyasani; Marianne W Mureithi; Omu A Anzala
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

6.  Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.

Authors:  Suzanne Day; Meredith Blumberg; Thi Vu; Yang Zhao; Stuart Rennie; Joseph D Tucker
Journal:  J Int AIDS Soc       Date:  2018-10       Impact factor: 5.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.